Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

April 2027 90

  1. Study completion Combination of Novel Therapies for CKD Comorbid Depression Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04422652

  2. Study completion Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04507178

  3. Study completion WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04701684

  4. Primary completion WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04701684

  5. Study completion ACOART BTK RENEW:A Post Market Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04885985

  6. Primary completion Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05168462

  7. Primary completion Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05569382

  8. Study completion Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05776420

  9. Primary completion Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05776420

  10. Study completion CTSN Embolic Protection Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06027788

  11. Primary completion CTSN Embolic Protection Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06027788

  12. Primary completion Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06634121

  13. Primary completion Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06925698

  14. Study completion Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07587294

  15. Primary completion Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07587294

  16. Study start The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That Are Shockable in Cardiac Arrest Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818785

  17. Study completion Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03907046

  18. Primary completion Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03907046

  19. Study completion Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05340582

  20. Primary completion MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05409989

  21. Primary completion ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05932615

  22. Primary completion Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06712030

  23. Primary completion Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06735534

  24. Primary completion CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06959121

  25. Study completion Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07093476

  26. Primary completion Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282743

  27. Primary completion A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07306182

  28. Primary completion DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07483801

  29. Primary completion Butylphthalide for Brain Edema After Endovascular Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07528456

  30. Primary completion Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537088

  31. Study completion Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575984

  32. Primary completion Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575984

  33. Study completion Using Mobile Stress Management to Reduce Hypertension in African American Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594808

  34. Study start Trial of CGM Technology in Persons Living With Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07639593

  35. Primary completion The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739160

  36. Study completion KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07805213

  37. Primary completion KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07805213

  38. Study completion LDL Cholesterol Reduction Following Ezetimibe Initiation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07839741

  39. Primary completion A Study of HRS-4729 Injection in Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843862

  40. Study completion Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877116

  41. Primary completion Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877116

  42. Study completion Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487950

  43. Primary completion Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487950

  44. Study completion Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05128513

  45. Primary completion Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05128513

  46. Primary completion A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07340320

  47. Primary completion DUTCH Weight Control in Atrial Fibrillation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06184633

  48. Study start A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07788989

  49. Study completion A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07340320

  50. Study completion Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03417388

  51. Study completion Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06307652

  52. Primary completion Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06307652

  53. Study completion Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06858878

  54. Primary completion A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107945

  55. Study completion Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07527078

  56. Primary completion Sex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07580547

  57. Study completion Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07509645

  58. Primary completion Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07509645

  59. Study completion Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07175428

  60. Study completion Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07403669

  61. Primary completion A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06731075

  62. Primary completion A Study of DII235 in Adults With Elevated Lipoprotein(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07235046

  63. Primary completion Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06987695

  64. Study completion Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03994471

  65. Study start Novel Wearable Device for Heart Failure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05642650

  66. Primary completion A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07610278

  67. Primary completion Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613840

  68. Study completion Neurovascular Transduction During Exercise in Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02947750

  69. Primary completion Neurovascular Transduction During Exercise in Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02947750

  70. Primary completion Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04924322

  71. Primary completion The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05034432

  72. Primary completion Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06369142

  73. Primary completion Esprit BTK Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06656364

  74. Primary completion Study on the Aortic Arch Single Branch Stent Graft System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06915545

  75. Study completion A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064486

  76. Primary completion A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064486

  77. Primary completion Clinical Prospective ranDomized Trial to Evaluate the Non-inferiority of Left Bundle Branch Area Pacing Vs Cardiac ResynchronIzatioN Therapy With ECG guIded AV Optimization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107048

  78. Primary completion Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07119021

  79. Study completion Left Bundle Branch Area Pacing (LBBAP) PMCF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07217392

  80. Primary completion Left Bundle Branch Area Pacing (LBBAP) PMCF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07217392

  81. Study completion Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07335107

  82. Primary completion Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07566065

  83. Primary completion A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07695597

  84. Study completion A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07729475

May 2027 82

  1. Study completion DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05276219

  2. Primary completion DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05276219

  3. Study completion PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05313165

  4. Primary completion PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05313165

  5. Study completion Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05612035

  6. Study completion Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05996159

  7. Study completion DUTCH Weight Control in Atrial Fibrillation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06184633

  8. Primary completion VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06384599

  9. Study completion Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06504576

  10. Study completion Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06820567

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Using 3D Imaging to Optimize Bifurcation Stenting Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02972489

  2. Primary completion The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02982434

  3. Primary completion Epicardial Fat Pads Ablation During Coronary Surgery Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02984371

  4. Primary completion Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02999841

  5. Primary completion Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03016611

  6. Primary completion Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris Registry record

    Expected 2017-12-31; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03037047

  7. Primary completion Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072225

  8. Primary completion Low Dose Statins, Ezetimibe and Nutraceuticals Registry record

    Expected 2017-12-31; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03277079

  9. Study start Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest Registry record

    Expected 2018-01-01; that period ended on 2018-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03317197

  10. Primary completion Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin Registry record

    Expected 2018-01-30; that period ended on 2018-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03299296

  11. Study completion Exenatide for Myocardial Protection During Reperfusion Study Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01938235

  12. Study completion Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02010905

  13. Primary completion Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02010905

  14. Primary completion Sedation Depth in Neurocritical Care Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02317497

  15. Primary completion Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02493075

  16. Study completion Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02583438

  17. Primary completion The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02646267

  18. Primary completion Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02768064

  19. Study completion Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02792712

  20. Primary completion Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02792712

  21. Primary completion Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02869308

  22. Study completion Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients Registry record

    Expected 2018-01; that period ended on 2018-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02999841

  23. Study start The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis Registry record

    Expected 2018-02-01; that period ended on 2018-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03163329

  24. Study start Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients Registry record

    Expected 2018-02-15; that period ended on 2018-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271879

  25. Primary completion Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02502981

  26. Study completion NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02557217

  27. Study completion The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke. Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02668848

  28. Study completion Randomized Controlled Trial of Renal Denervation for Resistant Hypertension Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02900729

  29. Primary completion Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02916485

  30. Study completion The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02982434

  31. Study completion Epicardial Fat Pads Ablation During Coronary Surgery Registry record

    Expected 2018-02; that period ended on 2018-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02984371

  32. Study start Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record

    Expected 2018-03-06; that period ended on 2018-03-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03047772

  33. Study start Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement Registry record

    Expected 2018-03-15; that period ended on 2018-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03440268

  34. Study start CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients Registry record

    Expected 2018-03-26; that period ended on 2018-03-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03444857

  35. Study completion Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin Registry record

    Expected 2018-03-30; that period ended on 2018-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03299296

  36. Study start Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record

    Expected 2018-03-30; that period ended on 2018-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03398096

  37. Study completion Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02029885

  38. Study completion Pyridorin in Diabetic Nephropathy Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02156843

  39. Study completion Effects of Limb Ischemic Postconditioning in Young sICAS Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323425

  40. Primary completion Effects of Limb Ischemic Postconditioning in Young sICAS Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323425

  41. Study completion The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02418884

  42. Primary completion The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02418884

  43. Primary completion Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02508714

  44. Study completion Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02617069

  45. Primary completion Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03001960

  46. Study completion S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension Registry record

    Expected 2018-03-31; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03226340

  47. Primary completion S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension Registry record

    Expected 2018-03-31; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03226340

  48. Primary completion Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) Registry record

    Expected 2018-03; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03249285

  49. Study completion Low Dose Statins, Ezetimibe and Nutraceuticals Registry record

    Expected 2018-03-31; that period ended on 2018-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03277079

  50. Study completion Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study Registry record

    Expected 2018-04-01; that period ended on 2018-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03244241

  51. Primary completion Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study Registry record

    Expected 2018-04-01; that period ended on 2018-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03244241

  52. Study start Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record

    Expected 2018-04-01; that period ended on 2018-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03486561

  53. Study completion Exercise For Sub-acute Stroke Patients in Jamaica Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01392391

  54. Primary completion Exercise For Sub-acute Stroke Patients in Jamaica Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01392391

  55. Study completion Pressure Wire Guided Cardiac Resynchronisation Therapy Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01464502

  56. Primary completion Pressure Wire Guided Cardiac Resynchronisation Therapy Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01464502

  57. Study completion Perceval S Aortic Heart Valve Study- North America Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01810679

  58. Primary completion Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02007837

  59. Primary completion Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02067091

  60. Primary completion Diuretic Versus Placebo in Pulmonary Embolism Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02268903

  61. Study completion Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02654678

  62. Primary completion Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02654678

  63. Study completion Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Registry record

    Expected 2018-04-30; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797340

  64. Primary completion Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Registry record

    Expected 2018-04-30; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797340

  65. Study completion Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection. Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02915328

  66. Primary completion Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection. Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02915328

  67. Study completion Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI Registry record

    Expected 2018-04; that period ended on 2018-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03001960

  68. Study start Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy Registry record

    Expected 2018-05-14; that period ended on 2018-05-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02948998

  69. Study completion Diuretic Versus Placebo in Pulmonary Embolism Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02268903

  70. Study completion Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02424110

  71. Primary completion Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02424110

  72. Study completion Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02502981

  73. Primary completion Intensive Versus Conventional Digoxin Use in Patients With Heart Failure Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797145

  74. Study completion Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02869308

  75. Study completion Assessing Neurodevelopment in Congenital Heart Disease. Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02996630

  76. Primary completion Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting Registry record

    Expected 2018-05; that period ended on 2018-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03049085

  77. Study start Tecarfarin Anti-Coagulation Trial (TACT) Registry record

    Expected 2018-06-01; that period ended on 2018-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02522221

  78. Study start Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. Registry record

    Expected 2018-06-06; that period ended on 2018-06-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03501680

  79. Study start Effect of External Counter Pulsation on Coronary Artery Disease Registry record

    Expected 2018-06-08; that period ended on 2018-06-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075124

  80. Study start Effect of External Counter Pulsation on Ischemic Stroke Registry record

    Expected 2018-06-10; that period ended on 2018-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075137

  81. Study start Neuroprotectant for Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2018-06-15; that period ended on 2018-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03546283

  82. Study completion Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02303639

  83. Study completion Dose-effect Relationship of Rt-PA on ICH Evacuation Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02472574

  84. Primary completion Dose-effect Relationship of Rt-PA on ICH Evacuation Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02472574

  85. Study completion Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02493075

  86. Primary completion Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02527811

  87. Primary completion A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641652

  88. Study completion Intensive Versus Conventional Digoxin Use in Patients With Heart Failure Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797145

  89. Primary completion Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02901704

  90. Primary completion Study of Safety and Efficacy of a Left Atrial Appendage Occulder Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02937025

  91. Study completion Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02979561

  92. Primary completion Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02979561

  93. Study completion To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent Registry record

    Expected 2018-06; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03089450

  94. Primary completion Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record

    Expected 2018-06-30; that period ended on 2018-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03398096

  95. Primary completion the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy Registry record

    Expected 2018-07-10; that period ended on 2018-07-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03230851

  96. Primary completion Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Registry record

    Expected 2018-07; that period ended on 2018-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02607943

  97. Primary completion Adenosine as an Adjunct to Blood Cardioplegia Registry record

    Expected 2018-07; that period ended on 2018-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02681913

  98. Primary completion Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC) Registry record

    Expected 2018-07; that period ended on 2018-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02826200

  99. Primary completion Ad-HGF Treatment for Myocardial Infarction Registry record

    Expected 2018-07; that period ended on 2018-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02844283

  100. Primary completion A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Registry record

    Expected 2018-07-31; that period ended on 2018-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02920593